Barclays’s Cardiovascular Systems, Inc. CSII Stock Holding History

Barclays’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-120,700	Closed	-$5.87M	–	6589
2019 Q4	$5.87M	Buy	+120,700	New	+$5.5M	﹤0.01%	1846
2018 Q3	–	Sell	-50,000	Closed	-$1.62M	–	7495
2018 Q2	$1.62M	Buy	+50,000	New	+$1.38M	﹤0.01%	2770

Other funds holding CSII

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's CSII Position: Q2 2023 in Review

Barclays sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 32,041 shares — an estimated $636K sold.

Barclays first reported a position in CSII in Q2 2013 and held it in 40 quarters. The position peaked at $4.18M in Q2 2019. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Barclays reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Barclays sold 32,041 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $636K.
Barclays first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 40 quarters.
Barclays's Cardiovascular Systems, Inc. position peaked at $4.18M in Q2 2019.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.